By Monica J. Smith
Historically, although survival has been the same whether patients undergo breast-conserving surgery or mastectomy, local recurrence rates were higher in those who chose BCS. But modern-era, multimodality treatment significantly reduces the risk for recurrence in patients who undergo BCS, according to a new study, data that may help inform patients making treatment decisions.
“We know that the rates of local recurrence after BCS are declining, which could be attributable